Improving opioid treatment outcomes for African American and Hispanic populations through cultural competency.
From Workforce Diversity to Key Cultural Competency Strategies to End Racial Disparities in Opioid Treatment Outcomes Across the Nation
This study is looking at how understanding different cultures and having a diverse healthcare team can help African American and Hispanic people get better access to opioid treatment, with the hope of making treatment fairer for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-10983740 on NIH RePORTER |
What this research studies
This research investigates how culturally competent strategies and workforce diversity can enhance access to opioid treatment for African American and Hispanic individuals. By analyzing data from the National Drug Abuse Treatment System Survey and collecting new data, the study aims to evaluate the impact of culturally and linguistically appropriate services on treatment processes such as wait times and medication dosages. The goal is to identify effective methods to reduce racial and ethnic disparities in opioid use disorder treatment across the nation.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American and Hispanic individuals seeking treatment for opioid use disorder.
Not a fit: Patients who do not identify as African American or Hispanic may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access and outcomes in opioid treatment for minority populations.
How similar studies have performed: Previous research has shown that culturally competent care can improve health outcomes, suggesting that this approach may be effective in addressing disparities in opioid treatment.
Where this research is happening
College Station, United States
- Texas A&m University — College Station, United States (Active)
Researchers
- Principal investigator: Howard, Daniel L — Texas A&m University
- Study coordinator: Howard, Daniel L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.